Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Days Sales Outstanding : 44.60 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Days Sales Outstanding?

Hubei Hongyuan Pharmaceutical Technology Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥208 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Revenue for the three months ended in Mar. 2024 was ¥426 Mil. Hence, Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 44.60.

The historical rank and industry rank for Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding or its related term are showing as below:

SZSE:301246' s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.65 Med: 27.66 Max: 46.57
Current: 38.82

During the past 10 years, Hubei Hongyuan Pharmaceutical Technology Co's highest Days Sales Outstanding was 46.57. The lowest was 18.65. And the median was 27.66.

SZSE:301246's Days Sales Outstanding is ranked better than
80.52% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs SZSE:301246: 38.82

Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding declined from Mar. 2023 (47.75) to Mar. 2024 (44.60).

Hubei Hongyuan Pharmaceutical Technology Co Days Sales Outstanding Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Days Sales Outstanding Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

21.77

27.68

27.63

39.69

46.57

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															47.75	38.44	34.25	39.49	44.60

Competitive Comparison of Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding falls into.

Hubei Hongyuan Pharmaceutical Technology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (313.738	+	210.574)	/	2 )	/	2054.882	*	365
=	262.156					/	2054.882	*	365
=	46.57

Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (210.574	+	205.914)	/	2 )	/	426.064	*	365 / 4
=	208.244					/	426.064	*	365 / 4
=	44.60

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hubei Hongyuan Pharmaceutical Technology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines